NEREUS (TRADIPITANT) Trademark
Trademark Overview
On Thursday, May 21, 2026, a trademark application was filed for NEREUS (TRADIPITANT) with the United States Patent and Trademark Office. The USPTO has given the NEREUS (TRADIPITANT) trademark a serial number of 99839227. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, May 21, 2026. This trademark is owned by Vanda Pharmaceuticals Inc.. The NEREUS (TRADIPITANT) trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an overexpression
of the neuropeptide known as substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by
overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment and prevention of vomiting induced by motion
General Information
| Serial Number | 99839227 |
| Word Mark | NEREUS (TRADIPITANT) |
| Filing Date | Thursday, May 21, 2026 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Thursday, May 21, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an overexpression
of the neuropeptide known as substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by
overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment and prevention of vomiting induced by motion |
| NOT AVAILABLE | "(tradipitant)" |
| Pseudo Mark | NEREUS TRADIPITANT |
| Description of Mark | The mark consists of a stylized silhouette of a goat at left of the wording NEREUS in a stylized navy blue font, and the wording (TRADIPITANT) in a smaller stylized navy blue font below NEREUS. |
| Indication of Colors claimed | The color(s) navy blue is/are claimed as a feature of the mark. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 21, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Vanda Pharmaceuticals Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Washington, DC 20037
US |
Trademark Events
| Event Date | Event Description |
| Thursday, May 21, 2026 | NEW APPLICATION ENTERED |
| Thursday, May 21, 2026 | APPLICATION FILING RECEIPT MAILED |
